CCR5 and HIV infectious disease: Table 2 summarizes clinical trials of several CCR5 antagonists (maraviroc, vicriviroc, AZD5672, and leronlimab) for the treatment of metastatic CRC, advanced breast and pancreatic ductal carcinoma, and Kaposi's sarcoma associated with HIV infection (Table 2).